Refinery 29
This is the first retinoid to safely treat acne on your face, chest, shoulders and back
When it comes to acne, the conversation is usually about ways to treat it or how it can cause anxiety, depression and low self-esteem.1 It usually involves de-stigmatizing a skin problem so prevalent that it affects up to 50 million Americans annually .2 It is usually about facial acne. According to certified dermatologist, Dr. Julie Harper, body acne is not as much discussed as facial acne – although it is quite common. For Dr. Harper, it affects more than half of her patients with facial acne.3 “Truncal [the medical term for ‘chest, shoulders, and back’] acne can offer its own set of challenges, ”she explains. “There is a difference in how we treat facial and trunk acne, but the difference in the approach to treatment has not historically been based on evidence or data. In the end, we tend to treat acne on the trunk badly. It tends to stay out of sight, out of mind. ”For this reason, Dr. Harper says there is no proven treatment for body acne – so far, with the AKLIEF® Cream (tripharotene) Galderma, 0.005%, indicated for the treatment of acne that is proven safe for the face, chest, shoulders and back.4 It is an innovative prescription retinoid – the first retinoid molecule to be approved by the FDA in over 20 years for the treatment of acne.5 The retinoid molecule (active ingredient) is trifarotene, which specifically targets important factors that cause acne.6 “This selectivity of tripharotene means that the product is potent even in low concentrations”, says Dr. Harper, who is also a paid spokesperson for Galderma.7 “This low concentration gives us comfort from the point from a safety point of view to use this on larger surface areas, like the chest and the back. ”4 After consulting a dermatologist and AKLIEF Cream is prescribed, use as your doctor claims, applying a thin layer (one pump for the face, two pumps for the chest, shoulders, and back) and av protect the sun using sunscreen. and protective clothing – after that, you can see acne improving in as little as two weeks.4 [your acne] it is mild to moderate or severe, or on the face or trunk, it can be treated, ”says Dr. Harper. IMPORTANT SAFETY INFORMATION: Indication: AKLIEF ® (tripharotene) Cream 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older Adverse events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were irritation at the application site, itching at the application site (itching) and sunburn. Warnings / precautions: Patients using AKLIEF cream may experience erythema, scaling, dryness and burning / burning. Use a moisturizer from the beginning of the treatment and, if appropriate, depending on the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid the application of AKLIEF Cream on cuts, abrasions or eczematous or sunburned skin. The use of “wax” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and solar lamps. Wear sunscreen and protective clothing over treated areas when exposure cannot be avoided. You are encouraged to report the negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. All trademarks are the property of their respective owners. This information is not intended to be medical advice. Talk to your doctor about your medical concerns. 1 American Academy of Dermatology. Acne can affect more than your skin. https://www.aad.org/public/diseases/acne-and-rosacea/emotional-health-effects-of-acne. Accessed August 23, 2019.2 Chiu A. et al. The response of skin disease to stress. Amer. Medical Assoc. 2003. 139: 897-900.3 Del Rosso JQ et al. A closer look at truncal acne vulgaris: prevalence, severity and clinical significance. J Drugs Dermatol. 2007; 6: 597-600.4 Tan J, Thiboutot D, Popp G, Gooderham M, Lynde C, et al. Phase 3 randomized evaluation of treatment with 50 μg / g tripharotene cream for moderate facial and trunk acne. J Am Acad Dermatol. 2019. DOI: https://doi.org/10.1016/j.jaad.2019.02.044.5 British Association of Dermatologists. Topical tripharotene: a new retinoid. Br J Dermatol. 2018; 179: 231-232. 6Fisher GJ, et al. J Biol Chem 1994; 269 (32): 20629-35. 7Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, et al. Non-clinical and human pharmacology of the potent and selective topical retinoic acid γ receptor tripharotene agonist. Br J Dermatol. 2018; 179: 442-456. Like what you’re seeing? How about a little more kindness R29, right here?